Ugur Sahin, co-founder and CEO of BioNTech AG, a co-founder of Ganymed Pharmaceuticals, a co-founder and chair of the translational research institute TRON, and a co-founder of the CI3- Rhein-Main Cluster for Individualized Immune Intervention. Ugur Sahin will share recent developments in translating scientific ideas into innovations that help individual patients. Preliminary announcement attached.
Hannover Medical School
lecture Hall N, Building j 01